125 related articles for article (PubMed ID: 38228094)
1. Health-related complications during follow-up and their impact on blood cancer survivors - results from the 'Aftercare in Blood Cancer Survivors' (ABC) study.
Baum J; Lax H; Lehmann N; Merkel-Jens A; Beelen DW; Jöckel KH; Dührsen U
Acta Haematol; 2024 Jan; ():. PubMed ID: 38228094
[TBL] [Abstract][Full Text] [Related]
2. Patient-reported patterns of follow-up care in the 'Aftercare in Blood Cancer Survivors' (ABC) study.
Baum J; Lax H; Lehmann N; Merkel-Jens A; Beelen DW; Jöckel KH; Dührsen U
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10531-10542. PubMed ID: 37291404
[TBL] [Abstract][Full Text] [Related]
3. Patterns of follow-up care in adult blood cancer survivors-Prospective evaluation of health-related outcomes, resource use, and quality of life.
Lax H; Baum J; Lehmann N; Merkel-Jens A; Beelen DW; Jöckel KH; Dührsen U
Cancer Med; 2024 Apr; 13(7):e7095. PubMed ID: 38549460
[TBL] [Abstract][Full Text] [Related]
4. Fertility preservation and fulfillment of parenthood after treatment of hematological malignancies: results from the 'Aftercare in Blood Cancer Survivors' (ABC) study.
Schmitz C; Baum J; Lax H; Lehmann N; Gromke T; Beelen DW; Jöckel KH; Dührsen U
Int J Clin Oncol; 2020 Jun; 25(6):1187-1194. PubMed ID: 32140954
[TBL] [Abstract][Full Text] [Related]
5. Preventive health care in blood cancer survivors: results from the ABC study.
Baum J; Lax H; Lehmann N; Merkel-Jens A; Beelen DW; Jöckel KH; Dührsen U
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11531-11540. PubMed ID: 37395845
[TBL] [Abstract][Full Text] [Related]
6. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
7. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
8. Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemia.
Schleicher O; Horndasch A; Krumbholz M; Sembill S; Bremensdorfer C; Grabow D; Erdmann F; Karow A; Metzler M; Suttorp M
Front Oncol; 2022; 12():963223. PubMed ID: 36276159
[TBL] [Abstract][Full Text] [Related]
9. Cancer survivors' preference for follow-up care providers: a cross-sectional study from the population-based PROFILES-registry.
Huibertse LJ; van Eenbergen M; de Rooij BH; Bastiaens MT; Fossion LM; de la Fuente RB; Kil PJ; Koldewijn EL; Meier AH; Mommers RJ; Niemer AQ; Oddens JR; Oomens EH; Prins M; de Roos KP; Thissen MR; Timmermans MW; Wijsman BP; van de Poll-Franse LV; Ezendam NP
Acta Oncol; 2017 Feb; 56(2):278-287. PubMed ID: 28068157
[TBL] [Abstract][Full Text] [Related]
10. Morbidity burden in survivors of multiple myeloma who underwent autologous transplantation: A Bone Marrow Transplantation Survivor Study.
Arora M; Chen Y; Hageman L; Wu J; Landier W; Francisco L; Kung M; Ness E; Bosworth A; Pamukcuoglu M; Weisdorf DJ; Forman SJ; Armenian SH; Bhatia S
Cancer; 2020 Jul; 126(14):3322-3329. PubMed ID: 32413187
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing cancer survivors' experiences with follow-up cancer care: results from the pan-Canadian Experiences of Cancer Patients in Transition Study survey.
Delisle M; Fitch M; Nagaratnam K; Wang Y; Srikanthan A
Support Care Cancer; 2022 Nov; 30(11):9559-9575. PubMed ID: 36123549
[TBL] [Abstract][Full Text] [Related]
12. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
13. Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma.
Chowdhry AK; McHugh C; Fung C; Dhakal S; Constine LS; Milano MT
Cancer; 2015 May; 121(9):1436-45. PubMed ID: 25572913
[TBL] [Abstract][Full Text] [Related]
14. Survivors' perspectives on risks and benefits of Hodgkin lymphoma treatment: results of a survey by the German Hodgkin Study Group.
Kreissl S; Goergen H; Müller H; Meissner J; Mehnert A; Bürkle C; Fuchs M; Engert A; Behringer K; Borchmann P
Leuk Lymphoma; 2019 Jun; 60(6):1389-1398. PubMed ID: 30507313
[TBL] [Abstract][Full Text] [Related]
15. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
16. 'Re-engage' pilot study protocol: a nurse-led eHealth intervention to re-engage, educate and empower childhood cancer survivors.
Signorelli C; Wakefield CE; Johnston KA; Fardell JE; Brierley ME; Thornton-Benko E; Foreman T; Webber K; Wallace WH; Cohn RJ
BMJ Open; 2018 Apr; 8(4):e022269. PubMed ID: 29654052
[TBL] [Abstract][Full Text] [Related]
17. "This Graft-vs.-Host Disease Determines My Life. That's It."-A Qualitative Analysis of the Experiences and Needs of Allogenic Hematopoietic Stem Cells Transplantation Survivors in Germany.
Parisek M; Loss J; Holler E; Barata A; Weber D; Edinger M; Wolff D; Schoemans H; Herrmann A
Front Public Health; 2021; 9():687675. PubMed ID: 34277549
[No Abstract] [Full Text] [Related]
18. Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas.
Warlick ED; Tomblyn M; Cao Q; Defor T; Blazar BR; Macmillan M; Verneris M; Wagner J; Dusenbery K; Aurora M; Bachanova V; Brunstein C; Burns L; Cooley S; Kaufman D; Majhail NS; McClune B; McGlave P; Miller J; Oran B; Slungaard A; Vercellotti G; Weisdorf DJ
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1025-32. PubMed ID: 21047561
[TBL] [Abstract][Full Text] [Related]
19. [Second primary malignancy among cancer survivors - epidemiology, prognosis and clinical relevance].
Grundmann RT; Meyer F
Zentralbl Chir; 2012 Dec; 137(6):565-74. PubMed ID: 22426967
[TBL] [Abstract][Full Text] [Related]
20. Semen quality in non-Hodgkin lymphoma survivors: a monocentric retrospective study.
Pallotti F; Pelloni M; Faja F; Di Chiano S; Di Rocco A; Lenzi A; Lombardo F; Paoli D
Hum Reprod; 2021 Jan; 36(1):16-25. PubMed ID: 33257989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
